UK NICE refers Baclofen as a priority for consideration of advice to medical profession

Here is a letter I received from the NICE, the contents of which are self explanatory:

 

Dear David

 

Thank you for contacting the National Institute for Health and Care Excellence (NICE).

 

I am responding to your email in Teresa’s absence.

 

Thank you for your email, which I have passed to the team responsible for our Evidence Summaries: unlicensed and off-label medicines (ESUOM) work programme.

 

They have informed me that the topic of Baclofen to treat alcohol dependence is on the list of prioritised topics to be considered via the topic selection process as outlined in the following process statement:

http://publications.nice.org.uk/evidence-summaries-unlicensed-and-off-label-medicines-integrated-process-statement-pmg14

 

I am sorry that I do not have further information to provide you with at this stage.

 

Kind regards,

Natalie

 

Natalie Whelan

Communications Executive (Enquiry Handling)

National Institute for Health and Care Excellence